Is this you? Create Your Porfile
Avatar

Kazuho Tanaka

Bayer Corporation

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Kazuho Tanaka is active.

Explore More

Publication

Featured researches published by Kazuho Tanaka.

Archive | 2004

2-aminopyrimidine derivatives

Hiroki Sato; Kazuho Tanaka; Makoto Shimazaki; Klaus Urbahns; Katsuya Sakai; Florian Gantner; Kevin Bacon

Archive | 2004

Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani

Archive | 2003

Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2

Kevin Bacon; Yuji Koriyama; Yoshihisa Manabe; Hiroki Sato; Hiromi Sugimoto; Kazuho Tanaka; Klaus Urbahns; Ly Tai Wie; Takashi Yoshino

Archive | 2002

Pyrimido [4,5-b] indole derivatives

Timothy B. Lowinger; Makoto Shimazaki; Hiroki Sato; Kazuho Tanaka; Naoki Tsuno; Karsten Marx; Masaru Yamamoto; Klaus Urbahns; Florian Gantner; Hiromi Okigami; Kosuke Nakashima; Keisuke Takeshita; Kevin Bacon; Hiroshi Komura; Nagahiro Yoshida

Archive | 2006

DERIVADOS DE ACIDO PIRIMIDINILACETICO UTEIS PARA O TRATAMENTO DE DOENCAS MEDIADAS POR CRTH2

Tai Wie Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns

Archive | 2004

Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate For treatment of diseases mediated by CRTH2 suitable pyrimidine

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani

Archive | 2004

For treatment of diseases mediated by CRTH2 suitable pyrimidine

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani

Archive | 2004

Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate

Tai-Wei Ly; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns; Masanori Seki; Takuya Shintani

Archive | 2004

Pyrimidine derivatives which are useful for the treatment of CRTH2-mediated diseases

Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Klaus Urbahns; Masanori Seki; Yoshihisa Manabe; Takuya Shintani; Tai-Wei Ly; Kevin Bacon

Archive | 2003

Pyrimidin-acetic acid derivatives useful for the treatment of CRTH2-related diseases

Tai Wie; Yuji Koriyama; Takashi Yoshino; Hiroki Sato; Kazuho Tanaka; Hiromi Sugimoto; Yoshihisa Manabe; Kevin Bacon; Klaus Urbahns

Explore More

Collaboration

Dive into the Kazuho Tanaka's collaboration.

Top Co-Authors
Avatar

Kevin Bacon

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Hiromi Sugimoto

Bayer

View shared research outputs
Top Co-Authors
Avatar

Takashi Yoshino

Bayer

View shared research outputs
Top Co-Authors
Avatar

Yuji Koriyama

Bayer

View shared research outputs
Top Co-Authors
Avatar

Klaus Urbahns

Bayer

View shared research outputs
Top Co-Authors
Avatar

Hiroki Sato

Tokyo Medical University

View shared research outputs
Top Co-Authors
Avatar

Masanori Seki

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Takuya Shintani

Bayer

View shared research outputs
Top Co-Authors
Avatar

Klaus Urbahns

Bayer

View shared research outputs
Top Co-Authors
Avatar

Hiroki Sato

Tokyo Medical University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge